ReviewFrontiers in immunology2025

It's about TIME - Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma.

Christin Knickmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.